A Phase III Long-term Study of TAK-536TCH in Participants With Essential Hypertension
Status:
Completed
Trial end date:
2016-04-25
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety of long-term administration of TAK-536,
amlodipine (AML), and hydrochlorothiazide (HCTZ) in participants with essential hypertension.